SI
SI
discoversearch

Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4675 127 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Anyone follow this one. Worth magazine has labeled ISIP the next Microsoft.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4675Down over 10% with no news that I have seen. Has anyone seen something that can scots40-7/25/2017
4674Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-5/29/2017
4673fda.gov Warning letter to an investigator in amyloidosis trial.scaram(o)uche-5/10/2017
4672I see NO NEWS out, yet the stock is down 6% on heavy volume. The drop started ascots40-5/10/2017
4671>>I bought a mini position at the close, looking for 30% or so retrace of tuck-4/8/2016
4670Ionis' TTR-rx program had a superficially strange hiccup today. It's rutuck-4/7/2016
4669WESTON, Mass. and CARLSBAD, Calif., Sept. 9, 2013 /PRNewswire/ -- Biogen Idec (Bnigel bates19/9/2013
4668Anyone still interested in ISIS? For example, what should an investor make ofDSMIA-6/8/2013
4667So Aegerion's drug and Isis' kynamro both given a thumbs up by the AC, wtuck-10/18/2012
4666Hi....you fellows aren't following ISIS anymore? Nice move since February...temco2-9/4/2012
4665Competitor KaroBio stops development of their lead drug, which was aiming at thetuck-2/14/2012
4664ISIS partners a niche drug early. Not sure how big this market is in dollars. tuck21/4/2012
4663Pfizer is taking Excaliard out, and Isis will get a portion of upfront , milestotuck-11/22/2011
4662Genzyme and Isis Announce Submission of European Marketing Authorization Applicabob zagorin-7/28/2011
4661Entrepreneurship Published online: 21 July 2011, doi:10.1038/bioe.2011.7 The Isibob zagorin-7/27/2011
4660Piper Jaffray Updates On ISIS Following Shareholders Meeting By BenzingaStaffT Bbob zagorin-6/20/2011
4659repost from IV "...JEFFRIES WEBCAST I just listened to Lynn's presentabob zagorin-6/10/2011
4658Isis Pharmaceuticals announces publication of new data concerning microRNA-33 Rebob zagorin-6/7/2011
4657>> Box 1 | The many faces of antisense therapy FROM THE FOLLOWING ARTICLEbob zagorin-6/2/2011
4656The long march of antisense >> Nature Reviews Drug Discovery 10, 401-402 bob zagorin-6/2/2011
4655COMPOUNDS AND METHODS FOR MODULATING PROTEIN EXPRESSION United States Patent Appbob zagorin-5/27/2011
4654Isis Initiates Phase 1 Study of ISIS-TTRRx and Earns $5 Million Milestone Paymenbob zagorin-5/19/2011
4653$3 Million Here, $1.5 Billion There By Brian Orelli | More Articles (Motley Foobob zagorin-5/18/2011
4652Isis Earns $3 Million Payment as Collaboration With GSK Expands Press Release Sobob zagorin-5/16/2011
4651Mipo Morningstar gives 60% chance of approval. Blockbuster potential. torontostbob zagorin-5/15/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.